Carnosic acid inhibits the proliferation and migration capacity of human colorectal cancer cells

Barni,M. V.; Carlini,M. J.; Cafferata,E. G.; Puricelli,L.; Moreno,S.

doi:10.3892/or.2012.1630

Carnosic acid inhibits the proliferation and migration capacity of human colorectal cancer cells

Authors:
- M. V. Barni
- M. J. Carlini
- E. G. Cafferata
- L. Puricelli
- S. Moreno
View Affiliations

Affiliations: Foundation Institute Leloir, IIBBA-CONICET, CABA 1405 Buenos Aires, Argentina, Foundation Institute Leloir, IIBBA-CONICET, Av. Patricias Argentinas 435, CABA 1405 Buenos Aires, Argentina
Published online on: January 11, 2012 https://doi.org/10.3892/or.2012.1630
Pages: 1041-1048

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Colorectal cancer (CRC) is the third most common malignant neoplasm worldwide. The objective of this study was to examine whether carnosic acid (CA), the main antioxidant compound of Rosmarinus officinalis L., would inhibit the cell viability of three CRC cell lines: Caco-2, HT29 and LoVo in a dose-dependent manner, with IC50 values in the range of 24-96 µM. CA induced cell death by apoptosis in Caco-2 line after 24 h of treatment and inhibited cell adhesion and migration, possibly by reducing the activity of secreted proteases such as urokinase plasminogen activator (uPA) and metalloproteinases (MMPs). These effects may be associated through a mechanism involving the inhibition of the COX-2 pathway, because we have determined that CA downregulates the expression of COX-2 in Caco-2 cells at both the mRNA and protein levels. Therefore, CA modulates different targets involved in the development of CRC. These findings indicate that carnosic acid may have anticancer activity and may be useful as a novel chemotherapeutic agent.

View Figures

View References

1	Bruce WR, Giacca A and Medline A: Possible mechanisms relating diet and risk of colon cancer. Cancer Epidemiol Biomarkers Prev. 9:1271–1279. 2000.PubMed/NCBI
2	Storz P: Reactive oxygen species in tumor progression. Front Biosci. 10:1881–1896. 2005. View Article : Google Scholar : PubMed/NCBI
3	Kundu JK and Surh YJ: Epigallocatechin gallate inhibits phorbol ester-induced activation of NF-κB and CREB in mouse skin. Ann NY Acad Sci. 1095:504–512. 2007.PubMed/NCBI
4	Kellof GJ, Crowell JA, Steele VE, Lubert RA, Malone WA, Boone CW, Koplovich L, Hawk ET, Liberman R, Lawrence JA, Ali I, Viner JL and Sigman CC: Progress in cancer chemoprevention: development of diet-derived chemopreventive agents. J Nutr. 130:S467–S471. 2000.PubMed/NCBI
5	Friedl P and Wolf K: Tumor-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer. 3:362–374. 2003. View Article : Google Scholar : PubMed/NCBI
6	Lai KC, Huang AC, Hsu SC, Kuo CL, Yang JS, Wu SH and Chung JG: Benzyl Isothiocyanate (BITC) Inhibits migration and invasion of human colon cancer HT29 cells by inhibiting matrix metalloproteinase-2/-9 and urokinase plasminogen (uPA) through PKC and MAPK signaling pathway. J Agric Food Chem. 58:2935–2942. 2010.
7	Cao Y and Prescott SM: Many actions of cyclooxygenase-2 in cellular dynamics and in cancer. J Cell Physiol. 190:279–286. 2002.PubMed/NCBI
8	Philip M, Rowley DA and Schreiber H: Inflammation as a tumor promoter in cancer induction. Semin Cancer Biol. 14:433–439. 2004.PubMed/NCBI
9	Tsujii M, Kawano S and Dubois RN: Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA. 94:3336–3340. 1997.PubMed/NCBI
10	Lee KW, Bode AM and Dong Z: Molecular targets of phytochemicals for cancer prevention. Nat Rev Cancer. 11:211–218. 2011. View Article : Google Scholar : PubMed/NCBI
11	Aggarwal BB and Shisodia S: Suppression of the nuclear factor-kappaB activation pathway by spice-derived phytochemicals: reasoning for seasoning. Ann N Y Acad Sci. 1030:434–441. 2004. View Article : Google Scholar : PubMed/NCBI
12	Cheung S and Tai J: Anti-proliferative and antioxidant properties of rosemary Rosmarinus officinalis. Oncol Rep. 17:1525–1531. 2007.PubMed/NCBI
13	Mengoni ES, Vichera G, Rigano LA, Rodriguez Puebla ML, Galliano SR, Cafferata EE, Pivetta OH, Moreno S and Vojnov AA: Suppression of COX-2, IL-1β and TNF-α expression and leukocyte infiltration in inflamed skin by bioactive compounds from Rosmarinus officinalis L. Fitoterapia. 8:414–421. 2011.
14	Steiner M, Priel I, Giat J, Levy J, Sharoni Y and Danilenko M: Carnosic acid inhibits proliferation and augments differentiation of human leukemic cells induced by 1,25-dihydroxyvitamin D3 and retinoic acid. Nutr Cancer. 41:135–144. 2001. View Article : Google Scholar : PubMed/NCBI
15	Danilenko M, Wang X and Studzinski GP: Carnosic acid and promotion of monocytic differentiation of HL60-G cell initiated by other agents. J Natl Cancer Inst. 93:1224–1233. 2001.PubMed/NCBI
16	Danilenko M, Wang Q, Wang X, Levy J, Sharoni Y and Studzinski GP: Carnosic acid potentiates the antioxidant and prodifferentiation effects of 1α,25-dihydroxyvitamin D₃ in leukemia cells but does not promote elevation of basal levels of intracellular calcium. Cancer Res. 63:1325–1332. 2003.
17	Yu YM, Lin CH, Chan HC and Tsai HD: Carnosic acid reduces cytokine-induced adhesion molecules expression and monocyte adhesion to endothelial cells. Eur J Nutr. 48:101–106. 2009.PubMed/NCBI
18	Yu YM, Lin HC and Chang WC: Carnosic acid prevents the migration of human aortic smooth muscle cells by inhibiting the activation and expression of matrix metalloproteinase-9. Br J Nutr. 100:731–738. 2008.PubMed/NCBI
19	Moreno S, Scheyer T, Romano CS and Vojnov A: Antimicrobial and antioxidant activities of Argentinean Rosmarinus officinalis L. extracts. Free Radic Res. 40:223–231. 2006.
20	Romano CS, Abadi K, Repetto V, Vojnov A and Moreno S: Synergistic antioxidant and antibacterial activity of rosemary plus butylated derivatives. Food Chem. 115:456–461. 2008. View Article : Google Scholar
21	Barni MV, Fontanals A and Moreno S: Study of the antibiotic Efficacy of an ethanolic extract from Rosmarinus officinalis against Staphylococcus aureus in two skin infection models in mice. BLACPMA. 8:219–223. 2009.
22	He J, Xiao Y, Casiano CA and Zhang L: Role of mitochondrial cytochrome c in cocaine-induced apoptosis in coronary artery endothelial cells. J Pharmacol Exp Ther. 295:896–903. 2000.PubMed/NCBI
23	Huang SS and Zheng RL: Rosmarinic acid inhibits angiogenesis and its mechanism of action in vitro. Cancer Lett. 239:271–280. 2006. View Article : Google Scholar : PubMed/NCBI
24	Aguirre Ghiso JA, Farías EF, Alonso DF and Bal de Kier Joffé E: Secretion of urokinase and metalloproteinase-9 induced by staurosporine is dependent on tyrosine kinase pathway in mammary tumor cells. Int J Cancer. 76:362–367. 1998.PubMed/NCBI
25	Visanji JM, Thompson DG and Padfield PJ: Induction of G2/M phase cell cycle arrest by carnosol and carnosic acid is associated with alteration of cyclin A and cyclin B1 levels. Cancer Lett. 237:130–136. 2006. View Article : Google Scholar : PubMed/NCBI
26	Pesakhov S, Khanin M, Studzinski GP and Danilenko M: Distinct combinatorial effects of the plant polyphenols curcumin, carnosic acid and silibinin on proliferation and apoptosis in acute myeloid leukemia cells. Nutr Cancer. 62:811–824. 2010. View Article : Google Scholar
28	Limab YC, Park HY, Hwang HS, Kang SU, Pyunc JH, Lee MH, Choi EC and Kimc C: (-)-Epigallocatechin-3-gallate (EGCG) inhibits HGF-induced invasion and metastasis in hypopharyngeal carcinoma cells. Cancer Lett. 271:140–152. 2008. View Article : Google Scholar : PubMed/NCBI
28	Park C, Moon DO and Choi IW: Curcumin induces apoptosis and inhibits prostaglandin E2 productionin synovial fibroblasts of patients with rheumatoid arthritis. Int J Mol Med. 20:365–372. 2007.PubMed/NCBI
29	Gupta RA and DuBois RN: Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer. 1:11–21. 2001. View Article : Google Scholar : PubMed/NCBI
30	Sobolewski C, Cerella C, Dicato M, Ghibelli M and Miederich M: The role of cyclooxygenase-2 in cell proliferation and cell death in human malignancies. Int J Cell Biol. 2010:1–21. 2010. View Article : Google Scholar : PubMed/NCBI
31	Leung E, McArthur D, Morris A and Williams N: Cyclooxygenase-2 inhibition prevents migration of colorectal cancer cells to extracellular matrix by down-regulation of matrix metalloproteinase-2 expression. Dis Colon Rectum. 51:342–347. 2007. View Article : Google Scholar : PubMed/NCBI